A novel sequence variant in exon 7 of CYP2C9 gene (CYP2C9*24) in a patient on warfarin therapy.

Herman, Darja; Peternel, Polona; Stegnar, Mojca; Breskvar, Katja; Dolzan, Vita

Herman, Darja; Peternel, Polona; Stegnar, Mojca; Breskvar, Katja; Dolzan, Vita.

Affiliation

Herman D; Institute of Biochemistry, Faculty of Medicine, Vrazov trg 2, St-1000 Ljubljana, Slovenia.

Thromb Haemost ; 95(1): 192-4, 2006 Jan.

Article in En | MEDLINE | ID: mdl-16543980

Subject(s)

Anticoagulants/therapeutic use; Aryl Hydrocarbon Hydroxylases/genetics; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants/administration & dosage; Anticoagulants/pharmacokinetics; Aryl Hydrocarbon Hydroxylases/metabolism; Atrial Fibrillation/drug therapy; Atrial Fibrillation/metabolism; Cytochrome P-450 CYP2C9; Drug Monitoring; Exons/genetics; Female; Genotype; Humans; Middle Aged; Mutation; Warfarin/administration & dosage; Warfarin/pharmacokinetics; Warfarin/therapeutic use

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Aryl Hydrocarbon Hydroxylases / Anticoagulants Limits: Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: Thromb Haemost Year: 2006 Document type: Article

Search on Google

XML

PubMed Links